Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Statin

The statins have achieved major importance as inhibitors of cholesterol biosynthesis and they are used in humans for the treatment of coronary disease. These compounds block isoprenoid formation by inhibiting the key enzyme, hydroxymethylglutaryl co-enzyme A reductase (HMGCoA reductase). This pathway is described in Chapter 5. The active form of the statins, in which the lactone ring is opened, has a formal resemblance to HMGCoA. This inhibition [Pg.66]

Biosynthetic experiments with variously labelled acetate units and [methyl- C] methionine established that the carbon skeleton of mevinolin was formed from nine acetate units, with the extra methyl group arising from methionine. The ester arose from two acetate units and a methionine. The oxygen atoms of the side chain at C-11, C-13 and C-15 were derived from the original acetate units whilst that at C-8 came from oxygen of the air. The cyclization reaction to form the bicyclic carbon skeleton may be a Diels-Alder cyclization (4.93 4.94). These are biosynthetically rather unusual. In the late stages of the biosynthesis, 4ot,5-dihydromonacolin L (4.95) is hydroxylated and dehydrogenated to form mevinolin. [Pg.67]

In the winter of 1507, there died at the Hospital Santa Maria Nuova in Florence an old man (il vecchio) (Fig. 5.134) who, shortly before his death, stated that in spite of his age, he felt no illness apart from a certain weakness. His age was one hundred years, more than double the statistical life expectancy at that time. [Pg.403]

Arteriosclerosis is one of the few internistic disease forms, the appearance of which can be demonstrated over many thousands of years. We owe this insight mainly to two circumstances favourable climatic conditions, and also the fact, that a number of ancient peoples wished their bodies not to be cremated or buried, but mummified and in this way preserved. [342] The disease is detectable by radiological investigations and dissection of mummies from Egypt, China [Pg.403]

136 English country doctor Caleb Hllller Parry (1755-1822). [Pg.404]

135 The autopsy of the body ofthe Ice-Man was not only the much-belated Investigation of a criminal case, but it also led to valuable information concerning the living conditions of men in the Neolithic period. [Pg.404]

Descriptions of some of the main secondary diseases following from arteriosclerosis have already been handed down to us from ancient times. Thus, one can find in the Hippocratic writings (Corpus Hippocraticum) indications of gangrene, stroke (apoplexia) and cardiac failure. But the explanation ofthe cause of such diseases first began in early modem times, when autopsies were carried out in increasing numbers to clarify the cause of death. [Pg.404]


The statins lower cholesterol by inhibiting the en zyme 3 hydroxy 3 methylglutaryl coenzyme A reduc tase which is required for the biosynthesis of meva Ionic acid (see Section 26 10) Mevalonic acid is an obligatory precursor to cholesterol so less mevalonic acid translates into less cholesterol... [Pg.1096]

The phenyl group became a practical protective group for carboxylic acids when Sharpless published a mild, effective one-step method for its conversion to a carboxylic acid. It has recently been used in a synthesis of the amino acid statine, where it served as a masked or carboxylic acid equivalent. ... [Pg.269]

The cholesterol-lowering agents called statins, such as simvastatin (Zocor) and pravastatin (Pravachol), are among the most widely prescribed drugs in the world. Identify the functional groups in both, and tell how the two substances differ. [Pg.105]

For ISIS 301012, a second-generation antisense inhibitor of apoB-100 in November 2006. Isis announced results from two Phase 2 clinical trials of ISIS 301012. In the first study repotted, patients with high cholesterol on stable doses of statins were treated with ISIS 301012 for 5 weeks. Patients who received 300 mg/week of ISIS 301012 in this study achieved a 51% reduction in LDL-cholesterol (LDL), a 42% reduction in total cholesterol (TC), and a 4l% reduction in triglycerides (TG) beyond the levels achieved with statins alone. [Pg.188]

Statins (3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors)... [Pg.228]

The antiinflammatory effects of statins likely result from their ability to inhibit the formation of mevalonic acid. Downstream products of this molecule include not only the end product, cholesterol, but also several isoprenoid intermediates that covalently modify ( pre-nylate ) certain key intracellular signaling molecules. Statin treatment reduces leukocyte adhesion, accumulation of macrophages, MMPs, tissue factor, and other proinflammatory mediators. By acting on the MHC class II transactivator (CIITA), statins also interfere with antigen presentation and subsequent T-cell activation. Statin treatment can also limit platelet activation in some assays as well. All these results support the concept that in addition to their favorable effect on the lipid profile, statins can also exert an array of antiinflammatory and immunomodulatory actions. [Pg.228]

Bone Metabolism. Figure 4 The mevalonate pathway. Interferences by statins and N-containing bisphosphonates are shown. [Pg.281]

Statins lower plasma cholesterol levels by inhibiting HMG-CoA reductase in the mevalonate pathway (Fig. 4). Some research has shown that certain statins (but not all) stimulate BMP-2 expression in osteoblasts, increase bone formation and mimic N-BP in that they inhibit bone resorption. The use of statins in osteoporosis is presently being investigated. [Pg.282]

HMG-CoA reductase inhibitors (statins). This effect has been suggested to account for some of the side effects of statins like myositis or rhabdomyolysis. [Pg.381]

Rate-limiting enzyme in cholesterol biosynthesis inhibition by statins results in reduction of plasma LDL-cholesterol levels. [Pg.596]

Furthermore, there is some evidence for pleiotrophic effects (e.g., effects on hemostasis, vascular function, anti-inflammatory effects, and stabilizing effects on atherosclerotic plaques) of statins. The clinical relevance of this (and the potential difference between the various statins) is at present uncertain but subject to intense investigation. [Pg.596]

There are currently marketed four naturally derived statins (lovastatin, pravastatin, simvastatin, and rosuvas-tatin) and two synthetic statins (atorvastatin and fluvas-tatin). The structure of these statins is shown in Fig. 2. [Pg.596]

The individual statins differ with respect to their pharmacological properties, but in general the clinical consequences of this are limited, but may occasionally... [Pg.596]

Mechanism of action of statins cholesterol synthesis pathway... [Pg.597]

HMG-CoA-Reductase Inhibitors. Figure 1 Mechanism of action of statins - cholesterol synthesis pathway. The conversion of acetyl CoA to cholesterol in the liver. The step of cholesterol biosynthesis inhibited by HMG-CoA reductase inhibitors (statins) is shown. [Pg.597]

Statins should not be used in pregnant women. If women with child-bearing potential are treated with statins efficient contraception should be secured. Statins should at present not be used in children unless they carry a very high risk of premature vascular-disease and in this case only by very experienced lipid specialists. [Pg.597]

Statins may reduce total cholesterol and LDL-cholesterol levels in plasma by 50-60%, reduce plasma... [Pg.597]

The effect of statins on plasma lipids and lipoproteins is rapidly seen and fully achieved after 4-6 weeks of treatment. The effect persists unchanged during continued use for several years, but after stopping the diug, LDL-cholesterol rapidly increases to pretreatment levels. Treatment with statins is therefore usually continued indefinitely and not as a short-term cure. Finally, it is generally advisable to use the statins that have documented their efficacy in clinical trials (evidence-based medicine). [Pg.598]


See other pages where Statin is mentioned: [Pg.1096]    [Pg.147]    [Pg.1096]    [Pg.840]    [Pg.840]    [Pg.186]    [Pg.186]    [Pg.190]    [Pg.430]    [Pg.87]    [Pg.493]    [Pg.494]    [Pg.494]    [Pg.494]    [Pg.223]    [Pg.228]    [Pg.259]    [Pg.280]    [Pg.280]    [Pg.454]    [Pg.454]    [Pg.584]    [Pg.596]    [Pg.596]    [Pg.596]    [Pg.596]    [Pg.597]    [Pg.597]    [Pg.598]    [Pg.598]   
See also in sourсe #XX -- [ Pg.191 ]

See also in sourсe #XX -- [ Pg.177 , Pg.178 , Pg.181 , Pg.187 ]

See also in sourсe #XX -- [ Pg.25 ]

See also in sourсe #XX -- [ Pg.322 , Pg.520 ]

See also in sourсe #XX -- [ Pg.11 , Pg.133 , Pg.134 ]

See also in sourсe #XX -- [ Pg.12 , Pg.34 , Pg.61 , Pg.83 , Pg.99 , Pg.120 ]

See also in sourсe #XX -- [ Pg.156 ]

See also in sourсe #XX -- [ Pg.372 ]

See also in sourсe #XX -- [ Pg.22 , Pg.48 , Pg.64 ]

See also in sourсe #XX -- [ Pg.169 , Pg.170 , Pg.171 , Pg.172 , Pg.173 , Pg.174 , Pg.175 , Pg.176 , Pg.177 , Pg.178 , Pg.179 , Pg.180 , Pg.181 ]

See also in sourсe #XX -- [ Pg.183 , Pg.191 ]

See also in sourсe #XX -- [ Pg.247 , Pg.323 , Pg.447 , Pg.479 , Pg.587 , Pg.685 ]

See also in sourсe #XX -- [ Pg.320 ]

See also in sourсe #XX -- [ Pg.318 ]

See also in sourсe #XX -- [ Pg.259 ]

See also in sourсe #XX -- [ Pg.23 , Pg.29 ]

See also in sourсe #XX -- [ Pg.201 ]

See also in sourсe #XX -- [ Pg.19 , Pg.19 , Pg.373 , Pg.374 ]

See also in sourсe #XX -- [ Pg.291 ]

See also in sourсe #XX -- [ Pg.367 ]

See also in sourсe #XX -- [ Pg.195 ]

See also in sourсe #XX -- [ Pg.280 ]

See also in sourсe #XX -- [ Pg.273 ]

See also in sourсe #XX -- [ Pg.137 , Pg.140 , Pg.149 , Pg.151 , Pg.185 ]

See also in sourсe #XX -- [ Pg.382 ]

See also in sourсe #XX -- [ Pg.86 ]

See also in sourсe #XX -- [ Pg.107 ]

See also in sourсe #XX -- [ Pg.87 , Pg.89 , Pg.99 ]

See also in sourсe #XX -- [ Pg.225 ]

See also in sourсe #XX -- [ Pg.719 , Pg.848 ]

See also in sourсe #XX -- [ Pg.9 , Pg.80 , Pg.81 ]

See also in sourсe #XX -- [ Pg.301 , Pg.524 ]

See also in sourсe #XX -- [ Pg.330 , Pg.369 ]

See also in sourсe #XX -- [ Pg.66 , Pg.170 ]

See also in sourсe #XX -- [ Pg.299 ]

See also in sourсe #XX -- [ Pg.3 , Pg.609 , Pg.718 , Pg.719 , Pg.744 , Pg.745 , Pg.848 ]

See also in sourсe #XX -- [ Pg.335 , Pg.470 ]

See also in sourсe #XX -- [ Pg.179 ]

See also in sourсe #XX -- [ Pg.67 , Pg.68 , Pg.69 , Pg.70 , Pg.74 , Pg.75 , Pg.76 , Pg.77 , Pg.78 , Pg.79 , Pg.80 , Pg.84 , Pg.95 , Pg.96 , Pg.101 , Pg.109 , Pg.110 , Pg.112 , Pg.260 , Pg.261 , Pg.271 , Pg.272 , Pg.273 , Pg.274 , Pg.275 , Pg.276 , Pg.277 , Pg.278 , Pg.279 , Pg.280 , Pg.281 , Pg.393 , Pg.432 , Pg.493 ]

See also in sourсe #XX -- [ Pg.11 ]

See also in sourсe #XX -- [ Pg.53 , Pg.59 ]

See also in sourсe #XX -- [ Pg.112 ]

See also in sourсe #XX -- [ Pg.417 , Pg.419 , Pg.446 , Pg.449 ]

See also in sourсe #XX -- [ Pg.748 , Pg.748 , Pg.1012 , Pg.1012 , Pg.1013 ]

See also in sourсe #XX -- [ Pg.277 , Pg.311 , Pg.312 , Pg.313 , Pg.314 , Pg.315 , Pg.316 ]

See also in sourсe #XX -- [ Pg.179 ]

See also in sourсe #XX -- [ Pg.132 ]

See also in sourсe #XX -- [ Pg.14 ]

See also in sourсe #XX -- [ Pg.26 , Pg.76 ]

See also in sourсe #XX -- [ Pg.656 ]

See also in sourсe #XX -- [ Pg.304 ]

See also in sourсe #XX -- [ Pg.660 ]

See also in sourсe #XX -- [ Pg.20 ]

See also in sourсe #XX -- [ Pg.403 , Pg.519 ]

See also in sourсe #XX -- [ Pg.761 ]

See also in sourсe #XX -- [ Pg.155 ]

See also in sourсe #XX -- [ Pg.368 ]

See also in sourсe #XX -- [ Pg.54 ]

See also in sourсe #XX -- [ Pg.63 ]

See also in sourсe #XX -- [ Pg.30 , Pg.67 , Pg.78 , Pg.79 , Pg.94 , Pg.222 , Pg.223 , Pg.224 , Pg.232 , Pg.258 , Pg.333 , Pg.339 , Pg.340 , Pg.344 , Pg.351 , Pg.354 , Pg.359 , Pg.366 , Pg.369 ]

See also in sourсe #XX -- [ Pg.5 , Pg.134 ]

See also in sourсe #XX -- [ Pg.138 ]

See also in sourсe #XX -- [ Pg.63 , Pg.343 , Pg.505 , Pg.1097 , Pg.1100 , Pg.1102 , Pg.1103 , Pg.1106 , Pg.1107 , Pg.1108 , Pg.1109 , Pg.1285 ]

See also in sourсe #XX -- [ Pg.1102 ]

See also in sourсe #XX -- [ Pg.403 ]

See also in sourсe #XX -- [ Pg.342 ]

See also in sourсe #XX -- [ Pg.66 , Pg.84 , Pg.89 , Pg.98 , Pg.106 , Pg.111 , Pg.112 , Pg.113 , Pg.114 , Pg.117 , Pg.125 , Pg.210 ]

See also in sourсe #XX -- [ Pg.18 ]

See also in sourсe #XX -- [ Pg.84 , Pg.85 , Pg.86 ]

See also in sourсe #XX -- [ Pg.229 ]

See also in sourсe #XX -- [ Pg.643 , Pg.645 , Pg.646 , Pg.647 , Pg.665 ]

See also in sourсe #XX -- [ Pg.1105 ]

See also in sourсe #XX -- [ Pg.7 , Pg.25 ]

See also in sourсe #XX -- [ Pg.185 ]

See also in sourсe #XX -- [ Pg.164 ]

See also in sourсe #XX -- [ Pg.138 , Pg.1198 ]

See also in sourсe #XX -- [ Pg.7 , Pg.25 ]

See also in sourсe #XX -- [ Pg.1095 ]

See also in sourсe #XX -- [ Pg.177 , Pg.232 ]




SEARCH



3-Hydroxy-3-methyl-glutaryl Statins

Aldehydes, a-amino statine synthesis

Alpha-statin

Amiodarone Statins

Amiodarone with statins

Anti-inflammatory statins

Atherosclerosis statins

Azole antifungals with statins

Bezafibrate Statins

Bile-acid sequestrants with statins

Biocatalysis statin side chains

Biocatalytic Routes to Statin Side Chains

Breast cancer statins

Cancer, treatment statins

Cardiovascular diseases statins

Cholesterol statins

Cholestyramine with statins

Cirrhosis statins

Clopidogrel Statins

Colchicine Statins

Colestipol Statins

Cyclosporine with statins

Daptomycin Statins

Diabetes mellitus statins

Digoxin with statins

Diltiazem Statins

Dipeptide analog, statine

Discovery of HMG-CoA-Reductase Inhibitors (Statins)

Epidemiological statin

Fenofibrate Statins

Fenofibrate with statins

Fibrates Statins

Fibrates with statins

Fluva statin

Fusidate Statins

Gemfibrozil Statins

Gemfibrozil and statins

Gemfibrozil with statins

HMG co-A reductase inhibitors statins

HMG-CoA reductase inhibitors statins)

Hormonal) Statins

Hydroxy-3 methylglutaryl coenzyme Statin therapy

Hyperlipidemia statins

Intermediates statins

Ischemic heart disease statins

Liver function tests statins

Look up the names of both individual drugs and their drug groups to access full information Statins

Macrolide antibiotics with statins

Medicines) Statins

Methyl -statine from

Myocardial infarction statins

Myopathy, statin-induced

Myopathy, with statins

NSAIDs) Statins

Nefazodone statins

Nephrotoxicity statins

Niacin interaction with statins

Nicotinic acid Statins

Nor-statine

Of -statine

Orlistat Statins

Osteoporosis statins

Pento statin

Pregnancy statins

Prescription drugs statins

Protease inhibitors with statins

Renal disease statins

Rhabdomyolysis statin therapy

Rhabdomyolysis with statins

Rhabdomyolysis, statin-associated

Rhabdomyolysis, statin-induced

SSRIs) Statins

Sildenafil 4- Statins

Statin (HMG-CoA reductase

Statin Lipitor

Statin drugs

Statin intervention

Statin lipid lowering drugs

Statin mitochondrial activity

Statin side chain

Statin therapy

Statin therapy primary prevention trials

Statin therapy secondary prevention trials

Statin treatment

Statin-induced muscle toxicity

Statine

Statine

Statine analogs

Statine analogues

Statine and Related Compounds

Statine biological activity

Statine diastereoselective synthesis

Statine synthesis

Statine synthesis, aldol reaction

Statine, asymmetric synthesis

Statins Alcohol

Statins Antacids

Statins Azoles

Statins Beta blockers

Statins Calcium-channel blockers

Statins Carbamazepine

Statins Ciclosporin

Statins Cimetidine

Statins Colestyramine

Statins Coumarins

Statins DERA-based routes

Statins Digoxin

Statins Diuretics

Statins Ezetimibe

Statins Fluconazole

Statins Itraconazole

Statins Ketoconazole

Statins Macrolides

Statins NNRTIs

Statins Phenytoin

Statins Protease inhibitors

Statins Rifampicin

Statins Ritonavir

Statins Saquinavir

Statins Tacrolimus

Statins Verapamil

Statins Voriconazole

Statins absorption

Statins action mechanisms

Statins adverse effects

Statins and TBI

Statins asymmetric synthesis

Statins atorvastatin

Statins atorvastatin intermediate

Statins benefits

Statins bile acid sequestrants

Statins cancer

Statins case-control study

Statins cataract

Statins chemical structure

Statins cholesterol-lowering effects

Statins clinical applications

Statins clinical trials

Statins combination therapy

Statins comparative effectiveness

Statins complications

Statins dementia

Statins distribution

Statins drug interactions

Statins effectiveness

Statins elimination

Statins fibrate drugs

Statins fluvastatin

Statins genes associated with response

Statins hepatotoxicity

Statins importance

Statins individual drugs

Statins inhibitors

Statins library

Statins lovastatin

Statins metabolism

Statins mevastatin

Statins musculoskeletal

Statins myopathy

Statins myotoxicity

Statins natural products

Statins niacin

Statins outcome studies

Statins overview

Statins pharmacokinetics

Statins pharmacologic properties

Statins pharmacology

Statins pravastatin

Statins prenylation

Statins prevention

Statins products

Statins reduction

Statins regulation

Statins safety

Statins side-effects

Statins structures

Statins tolerance

Statins total synthesis

Statins treatment intensity

Statins treatment monitoring

Statins ubiquinone

Statins with niacin

Stroke statins

Synthesis of -statine

Synthetic statins

Transformations of the DERA Product Toward Statins

Warfarin with statins

© 2024 chempedia.info